
Sign up to save your podcasts
Or
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
134 Listeners
13 Listeners
313 Listeners
107 Listeners
864 Listeners
248 Listeners
494 Listeners
688 Listeners
18 Listeners
278 Listeners
3,324 Listeners
1,113 Listeners
193 Listeners
514 Listeners
349 Listeners
60 Listeners
25 Listeners
426 Listeners
364 Listeners